Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Baxter
Boehringer Ingelheim
Johnson and Johnson
Medtronic

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Aurobindo Pharma Ltd Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?

AUROBINDO PHARMA LTD has two hundred and eighty-nine approved drugs.

There are twenty-eight tentative approvals on AUROBINDO PHARMA LTD drugs.

Summary for Aurobindo Pharma Ltd

Drugs and US Patents for Aurobindo Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd FAMOTIDINE famotidine TABLET;ORAL 206531-002 Apr 26, 2016 OTC No No   Start Trial   Start Trial
Aurobindo Pharma Ltd NORETHINDRONE ACETATE norethindrone acetate TABLET;ORAL 204236-001 Jan 8, 2016 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd LEVOFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER levofloxacin INJECTABLE;INJECTION 206919-002 Feb 10, 2016 AP RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd ARMODAFINIL armodafinil TABLET;ORAL 206069-001 Mar 6, 2018 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 202261-008 Aug 21, 2019 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd FUROSEMIDE furosemide INJECTABLE;INJECTION 212174-001 May 3, 2019 AP RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd MIRTAZAPINE mirtazapine TABLET, ORALLY DISINTEGRATING;ORAL 077376-004 Feb 28, 2006 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Merck
Medtronic
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.